Apertus Pharmaceuticals
St. Louis, Missouri, United States
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: Apertus Pharmaceuticals
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- St. Louis, Missouri, United States
- Website
- https://apertuspharma.com/contract-manufacturing/
- Modalities
- Oral Solid Dose, Topicals, Finished Dosage Forms, Small Molecule API
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Apertus Pharmaceuticals
Apertus Pharmaceuticals is a contract development and manufacturing organization (CDMO). Capabilities: Oral Solid Dose, Topicals, Finished Dosage Forms, Small Molecule API. 2 manufacturing sites registered with the U.S. FDA. Website: https://apertuspharma.com/contract-manufacturing/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Apertus Pharmaceuticals FDA Inspection History
2025-10
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-10-31 |
Apertus Pharmaceuticals
Ballwin, Missouri
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Frequently Asked Questions About Apertus Pharmaceuticals
How many FDA inspections does Apertus Pharmaceuticals have on record?
CDMO Signal tracks 1 FDA inspection for Apertus Pharmaceuticals, sourced from the FDA inspection database. See the full inspection history above.
Has Apertus Pharmaceuticals received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Apertus Pharmaceuticals.
Does Apertus Pharmaceuticals have a CDMO Signal Score?
Not yet. Apertus Pharmaceuticals is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Apertus Pharmaceuticals for a manufacturing program?
Use the free AI matchmaker to compare Apertus Pharmaceuticals against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
AbbVie Contract Manufacturing
North Chicago, Illinois, United States
Small Molecule API, High-Potency APIs, Biologics, ADC / Bioconjugation, Sterile Fill-Finish, Lyophilization, Prefilled Syringes, Oral Solid Dose, Hot-Melt Extrusion, Oral Liquids, Topicals
Pierre Fabre CDMO
Castres, France
Oral Solid Dose, Finished Dosage Forms, Non-sterile Liquids, Semi-solids & Liquids, Small Molecule API, High-Potency APIs, Packaging & Labeling
Zambon (Zach System)
Italy
Small Molecule API, Custom Synthesis, Oral Solid Dose, Finished Dosage Forms
Indoco Remedies
Mumbai, India
Small Molecule API, Intermediates, Custom Synthesis, Oral Solid Dose, Topicals
Wisdom Pharmaceutical
Haimen, Jiangsu, China
Small Molecule API, Sterile Injectables, Oral Solid Dose, Topicals, Veterinary
Compare Apertus Pharmaceuticals with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.